Idiopathic sclerosing peritonitis associated with florid mesothelial hyperplasia, ovarian fibromatosis, and endometriosis: A new disorder of abdominal mass

Luigi Frigerio, L Frigerio, Frigerio L, Gian Luca Taccagni, G L Taccagni, Taccagni Gl, Mariani A, Andrea Mariani, A Mariani, Giorgia Mangili, G Mangili, A Ferrari, Ferrari A, Augusto Ferrari
American journal of obstetrics and gynecology · 1997 · vol. 176(3) , pp. 721–722 · doi:10.1016/s0002-9378(97)70581-7 · PMID:9077640 · W2002747610
article OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This paper describes a novel disorder characterized by idiopathic sclerosing peritonitis, florid mesothelial hyperplasia, ovarian fibromatosis, and endometriosis presenting as abdominal masses.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A 35-year-old woman underwent exploratory laparotomy for ovarian enlargement, massive ascites, and intestinal obstruction. Sclerosing peritonitis associated with florid mesothelial hyperplasia, ovarian fibromatosis, and endometriosis were diagnosed postoperatively. We add to the literature this new association of bilateral ovarian enlargement, sclerosing peritonitis, and florid mesothelial hyperplasia.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Fibroma Ovarian Neoplasms Peritoneum Peritonitis Adult Ascites Ascites Endometriosis Female Fibroma Humans Hyperplasia Hyperplasia Intestinal Obstruction Intestinal Obstruction Intestine, Small Intestine, Small Ovarian Neoplasms Peritoneum

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (4)

References (4)

Cited by (4)

Source provenance

europepmc
last seen: 2026-08-01T06:07:04.264727+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:10:52.568893+00:00
License: CC0 · commercial use OK